Dr. Lal PathLabs Limited
LALPATHLAB
Rangering i aksjer
#4510
Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health... Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health assessment services, operating both domestically in India and across international borders. The company manages a comprehensive network of laboratories dedicated to conducting pathological investigations across various specialized fields. These include biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, in addition to other general pathological and radiological studies. Beyond its core testing operations, Dr. Lal PathLabs also offers laboratory staff training, technical support, and full-scale lab management services. As of March 31, 2022, its widespread infrastructure included 277 clinical laboratories, notably a National Reference Lab located in Delhi and a Regional Reference Lab in Kolkata. This is further bolstered by 4,731 patient service centers and 10,599 sample collection points. Founded in 1949, Dr. Lal PathLabs Limited maintains its corporate base in Gurugram, India.
Aksjekurs
$20.36
Markedsverdi
$3.40B
Endring (1 dag)
-0.80%
Endring (1 år)
15.31%
Land
IN
Handel Dr. Lal PathLabs Limited (LALPATHLAB)
Kategori
Healthcare
EPS for Dr. Lal PathLabs Limited (LALPATHLAB)
EPS per June 2026 TTM: $0.36
Ifølge de siste økonomiske rapportene og aksjekursen til Dr. Lal PathLabs Limited er selskapets nåværende EPS (TTM) $0.36. Ved slutten av 2024 hadde selskapet en EPS på $0.26, en økning sammenlignet med EPS-en i 2023 som var $0.18.
EPS-historikk for Dr. Lal PathLabs Limited fra 2011 til 2026
EPS ved slutten av hvert år
| År | EPS | Endre |
|---|---|---|
| 2026 (TTM) | $0.36 | 5.29% |
| 2025 | $0.34 | 32.47% |
| 2024 | $0.26 | 47.23% |
| 2023 | $0.18 | -36.18% |
| 2022 | $0.27 | 13.84% |
| 2021 | $0.24 | 32.58% |
| 2020 | $0.18 | 4.48% |
| 2019 | $0.17 | 8.81% |
| 2018 | $0.16 | 9.21% |
| 2017 | $0.15 | 20.76% |
| 2016 | $0.12 | -9.74% |
| 2015 | $0.13 | -4.00% |
| 2014 | $0.14 | 56.71% |
| 2013 | $0.09 | 67.73% |
| 2012 | $0.05 | 34.94% |
| 2011 | $0.04 | 0.00% |
EPS for lignende selskaper eller konkurrenter
| Selskap | EPS | EPS-forskjell | Land |
|---|---|---|---|
| $18.62 | 5,101.12% |
US
|
|
| $5.65 | 1,478.21% |
US
|
|
| $-1.36 | -479.89% |
US
|
|
| - | - |
CN
|
|
| $5.09 | 1,321.79% |
US
|
